{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:43:25Z","timestamp":1794915805882,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13014-019-1262-8","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T08:03:11Z","timestamp":1554278591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy"],"prefix":"10.1186","volume":"14","author":[{"given":"Rashmi","family":"Jadon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mererid","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Coles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Staffurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"issue":"8","key":"1262_CR1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.clon.2011.03.006","volume":"23","author":"B Benton","year":"2011","unstructured":"Benton B, Norton C, Lindsay JO, Dolan S, Andreyev HJ. Can nurses manage gastrointestinal symptoms arising from pelvic radiation disease? Clin Oncol (R Coll Radiol). 2011;23(8):538\u201351.","journal-title":"Clin Oncol (R Coll Radiol)."},{"issue":"10","key":"1262_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.clon.2007.08.011","volume":"19","author":"HJ Andreyev","year":"2007","unstructured":"Andreyev HJ. Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future. Clin Oncol (R Coll Radiol). 2007;19(10):790\u20139.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3 Suppl","key":"1262_CR3","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/j.ijrobp.2009.03.078","volume":"76","author":"JM Michalski","year":"2010","unstructured":"Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S123\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"1262_CR4","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","volume":"76","author":"BD Kavanagh","year":"2010","unstructured":"Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten Haken RK, et al. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S101\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"1262_CR5","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1016\/j.ijrobp.2009.08.074","volume":"76","author":"A Jackson","year":"2010","unstructured":"Jackson A, Marks LB, Bentzen SM, Eisbruch A, Yorke ED, Ten Haken RK, et al. The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S155\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1262_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.radonc.2015.02.010","volume":"115","author":"R Mouttet-Audouard","year":"2015","unstructured":"Mouttet-Audouard R, Lacornerie T, Tresch E, Kramar A, Le Tinier F, Reynaert N, et al. What is the normal tissues morbidity following helical intensity modulated radiation treatment for cervical cancer? Radiother Oncol. 2015;115(3):386\u201391.","journal-title":"Radiother Oncol"},{"issue":"4","key":"1262_CR7","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.ijrobp.2011.04.041","volume":"82","author":"C Deville","year":"2012","unstructured":"Deville C, Vapiwala N, Hwang WT, Lin H, Ad VB, Tochner Z, et al. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy. Int J Radiat Oncol Biol Phys. 2012;82(4):1389\u201396.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1262_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.clon.2010.01.005","volume":"22","author":"T Guerrero Urbano","year":"2010","unstructured":"Guerrero Urbano T, Khoo V, Staffurth J, Norman A, Buffa F, Jackson A, et al. Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation study. Clin Oncol (R Coll Radiol). 2010;22(3):236\u201344.","journal-title":"Clin Oncol (R Coll Radiol)."},{"issue":"1","key":"1262_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clon.2014.09.016","volume":"27","author":"F McDonald","year":"2015","unstructured":"McDonald F, Waters R, Gulliford S, Hall E, James N, Huddart RA. Defining bowel dose volume constraints for bladder radiotherapy treatment planning. Clin Oncol (R Coll Radiol). 2015;27(1):22\u20139.","journal-title":"Clin Oncol (R Coll Radiol)."},{"issue":"3","key":"1262_CR10","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ijrobp.2012.05.021","volume":"85","author":"F Isohashi","year":"2013","unstructured":"Isohashi F, Yoshioka Y, Mabuchi S, Konishi K, Koizumi M, Takahashi Y, et al. Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiation therapy for early-stage cervical cancer. Int J Radiat Oncol Biol Phys. 2013;85(3):728\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1262_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ijrobp.2013.11.214","volume":"88","author":"S Chopra","year":"2014","unstructured":"Chopra S, Dora T, Chinnachamy AN, Thomas B, Kannan S, Engineer R, et al. Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study. Int J Radiat Oncol Biol Phys. 2014;88(3):630\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"1262_CR12","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1080\/0284186X.2016.1176247","volume":"55","author":"H Lind","year":"2016","unstructured":"Lind H, Alevronta E, Steineck G, Waldenstrom AC, Nyberg T, Olsson C, et al. Defecation into clothing without forewarning and mean radiation dose to bowel and anal-sphincter among gynecological cancer survivors. Acta Oncol. 2016;55(11):1285\u201393.","journal-title":"Acta Oncol"},{"issue":"3","key":"1262_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijrobp.2012.09.035","volume":"85","author":"P Kelly","year":"2013","unstructured":"Kelly P, Das P, Pinnix CC, Beddar S, Briere T, Pham M, et al. Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2013;85(3):143\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1262_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.radonc.2004.11.001","volume":"74","author":"L Fokdal","year":"2005","unstructured":"Fokdal L, Honore H, Hoyer M, von der Maase H. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. Radiother Oncol. 2005;74(2):203\u201310.","journal-title":"Radiother Oncol"},{"issue":"4","key":"1262_CR15","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.ijrobp.2011.09.022","volume":"83","author":"J Huang","year":"2011","unstructured":"Huang J, Roberson JM, Ye H, Yan D. Dose-volume analysis of predictors for gastrointestinal toxicity after radiotherapy and concurrent fulldose gemcitabine for locally advanced pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2011;83(4):1120\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1262_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.ijrobp.2012.10.004","volume":"85","author":"PD Poorvu","year":"2013","unstructured":"Poorvu PD, Sadow CA, Townamchai K, Damato AL, Viswanathan AN. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes. Int J Radiat Oncol Biol Phys. 2013;85(5):1262\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1262_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.radonc.2007.06.013","volume":"84","author":"V Fonteyne","year":"2007","unstructured":"Fonteyne V, De Neve W, Villeirs G, De Wagter C, De Meerleer G. Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity. Radiother Oncol. 2007;84(2):156\u201363.","journal-title":"Radiother Oncol"},{"issue":"4","key":"1262_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ijrobp.2004.07.706","volume":"61","author":"M al-Abany","year":"2005","unstructured":"al-Abany M, Helgason AR, Cronqvist AK, Lind B, Mavroidis P, Wersall P, et al. Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum. Int J Radiat Oncol Biol Phys. 2005;61(4):1035\u201344.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1262_CR19","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/j.ijrobp.2012.03.065","volume":"84","author":"D Alsadius","year":"2012","unstructured":"Alsadius D, Hedelin M, Lundstedt D, Pettersson N, Wilderang U, Steineck G. Mean absorbed dose to the anal-sphincter region and fecal leakage among irradiated prostate cancer survivors. Int J Radiat Oncol Biol Phys. 2012;84(2):e181\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1262_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.radonc.2012.03.002","volume":"103","author":"F Buettner","year":"2012","unstructured":"Buettner F, Gulliford SL, Webb S, Sydes MR, Dearnaley DP, Partridge M. The dose-response of the anal sphincter region--an analysis of data from the MRC RT01 trial. Radiother Oncol. 2012;103(3):347\u201352.","journal-title":"Radiother Oncol"},{"issue":"4","key":"1262_CR21","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ijrobp.2005.10.002","volume":"64","author":"ST Peeters","year":"2006","unstructured":"Peeters ST, Lebesque JV, Heemsbergen WD, van Putten WL, Slot A, Dielwart MF, et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2006;64(4):1151\u201361.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1262_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijrobp.2010.08.023","volume":"82","author":"RJ Smeenk","year":"2012","unstructured":"Smeenk RJ, Hopman WP, Hoffmann AL, van Lin EN, Kaanders JH. Differences in radiation dosimetry and anorectal function testing imply that anorectal symptoms may arise from different anatomic substrates. Int J Radiat Oncol Biol Phys. 2012;82(1):145\u201352.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1262_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.radonc.2003.07.002","volume":"69","author":"D Vordermark","year":"2003","unstructured":"Vordermark D, Schwab M, Ness-Dourdoumas R, Sailer M, Flentje M, Koelbl O. Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate. Radiother Oncol. 2003;69(2):209\u201314.","journal-title":"Radiother Oncol"},{"issue":"5","key":"1262_CR24","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3109\/0284186X.2015.1118658","volume":"55","author":"EK Yeoh","year":"2016","unstructured":"Yeoh EK, Krol R, Dhillon VS, Botten R, Di Matteo A. Butters J, et al.. Predictors of radiation-induced gastrointestinal morbidity: a prospective, longitudinal study following radiotherapy for carcinoma of the prostate. Acta Oncol. 2016;55(5):604\u201310.","journal-title":"Acta Oncol"},{"issue":"1","key":"1262_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2004.07.020","volume":"73","author":"PC Koper","year":"2004","unstructured":"Koper PC, Jansen P, van Putten W, van Os M, Wijnmaalen AJ, Lebesque JV, et al. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial. Radiother Oncol. 2004;73(1):1\u20139.","journal-title":"Radiother Oncol"},{"issue":"2","key":"1262_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.ijrobp.2011.08.007","volume":"83","author":"RJ Smeenk","year":"2012","unstructured":"Smeenk RJ, Hoffmann AL, Hopman WP, van Lin EN, Kaanders JH. Dose-effect relationships for individual pelvic floor muscles and anorectal complaints after prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(2):636\u201344.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1262_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00066-005-1313-y","volume":"181","author":"P Mavroidis","year":"2005","unstructured":"Mavroidis P, al-Abany M, Helgason AR, Agren Cronqvist AK, Wersall P, Lind H, et al. Dose-response relations for anal sphincter regarding fecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Radiobiological study of 65 consecutive patients. Strahlenther Onkol. 2005;181(5):293\u2013306.","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"1262_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijrobp.2006.03.034","volume":"66","author":"ST Peeters","year":"2006","unstructured":"Peeters ST, Hoogeman MS, Heemsbergen WD, Hart AA, Koper PC, Lebesque JV. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys. 2006;66(1):11\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"1262_CR29","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3109\/0284186X.2015.1063779","volume":"54","author":"M Thor","year":"2015","unstructured":"Thor M, Olsson CE, Oh JH, Petersen SE, Alsadius D, Bentzen L, et al. Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancer. Acta Oncol. 2015;54(9):1326\u201334.","journal-title":"Acta Oncol"},{"issue":"2","key":"1262_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ijrobp.2013.09.053","volume":"88","author":"J Verma","year":"2014","unstructured":"Verma J, Sulman EP, Jhingran A, Tucker SL, Rauch GM, Eifel PJ, et al. Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the Para-aortic nodes in gynecologic cancer. Int J Radiat Oncol Biol Phys. 2014;88(2):357\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1262_CR31","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ijrobp.2009.08.043","volume":"78","author":"C Deville","year":"2010","unstructured":"Deville C, Both S, Hwang WT, Tochner Z, Vapiwala N. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010;78(3):763\u201372.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1262_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109\u201322.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1262_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","volume":"18","author":"JP Kirkpatrick","year":"2008","unstructured":"Kirkpatrick JP, Meyer JJ, Marks LB. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol. 2008;18(4):240\u20133.","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"1262_CR34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ijrobp.2010.09.018","volume":"82","author":"JB Adkison","year":"2012","unstructured":"Adkison JB, McHaffie DR, Bentzen SM, Patel RR, Khuntia D, Petereit DG, et al. Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82(1):184\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1262_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ijrobp.2014.11.015","volume":"91","author":"MA Ebert","year":"2015","unstructured":"Ebert MA, Foo K, Haworth A, Gulliford SL, Kennedy A, Joseph DJ, et al. Gastrointestinal dose-histogram effects in the context of dose-volume-constrained prostate radiation therapy: analysis of data from the RADAR prostate radiation therapy trial. Int J Radiat Oncol Biol Phys. 2015;91(3):595\u2013603.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1262_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13566-015-0205-8","volume":"4","author":"GLA Green","year":"2015","unstructured":"Green GLA, Zhang J, Ramsinghani N, Asawi S. Dose-volume relationship of acute and late small bowel toxicity from radiation therapy for prostate cancer: a veterans affairs study. J Radiat Oncol. 2015;4:411\u20135.","journal-title":"J Radiat Oncol"},{"issue":"5","key":"1262_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/01.coc.0000091355.26165.81","volume":"26","author":"D Taussky","year":"2003","unstructured":"Taussky D, Schneider U, Rousson V, Pescia R. Patient-reported toxicity correlated to dose-volume histograms of the rectum in radiotherapy of the prostate. Am J Clin Oncol. 2003;26(5):144\u20139.","journal-title":"Am J Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-019-1262-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T19:19:37Z","timestamp":1585768777000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-019-1262-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1262"],"URL":"https:\/\/doi.org\/10.1186\/s13014-019-1262-8","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"7 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"57"}}